Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuhong Liu

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Cancer Innovation|December 13, 2023
Severe graft-versus-host disease post allogeneic hematopoietic stem cell transplantation due to loss of HLA heterozygosity in recipient lymphocytes after full graft rejectionSong Xue, Lili Miao, Zimu Gong, et al.
ACS Applied Materials & Interfaces|June 10, 2026
An Astrocyte-Targeted Nanoplatform with Ultrasound-Responsive Fluorescence Switch for Synergistic Chemo-Sonothermal Therapy of Cognitive ImpairmentZengjin Wang, Peng Gao, Xuan Song, et al.
International Journal of Hematology|January 2, 2021
Clostridium perfringens sepsis in three patients with acute leukemia and review of the literatureFuhong Liu, Song Xue, Yongping Zhang, et al.
Clinical and Experimental Pharmacology & Physiology|June 2, 2022
Dihydroartemisinin protects blood-brain barrier permeability during sepsis by inhibiting the transcription factor SNAI1Fuhong Liu, Jing Liu, Hongjie Xiang, et al.
Leukemia & Lymphoma|April 20, 2022
Rapid response to avapritinib of acute myeloid leukemia with t(8;21) and <i>KIT</i> mutation relapse post allo-HSCTSong Xue, Wenqiu Huang, Fuhong Liu, et al.
International Journal of Laboratory Hematology|April 11, 2024
FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantationSong Xue, Wenqiu Huang, Yongping Zhang, et al.
Autoimmunity|February 25, 2015
STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopeniaZhenping Chen, Zhenxing Guo, Jingyao Ma, et al.
Cancer Chemotherapy and Pharmacology|December 23, 2023
Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathwayLiru Huang, Fuhong Liu, Xukai Liu, et al.
Annals of Hematology|November 10, 2022
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioningWenqiu Huang, Song Xue, Yongping Zhang, et al.
Fundamental & Clinical Pharmacology|October 27, 2020
Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cellsFengyun Dong, Xinghai Zhao, Jianning Wang, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cancer Innovation|December 13, 2023
Severe graft-versus-host disease post allogeneic hematopoietic stem cell transplantation due to loss of HLA heterozygosity in recipient lymphocytes after full graft rejectionSong Xue, Lili Miao, Zimu Gong, et al.
ACS Applied Materials & Interfaces|June 10, 2026
An Astrocyte-Targeted Nanoplatform with Ultrasound-Responsive Fluorescence Switch for Synergistic Chemo-Sonothermal Therapy of Cognitive ImpairmentZengjin Wang, Peng Gao, Xuan Song, et al.
International Journal of Hematology|January 2, 2021
Clostridium perfringens sepsis in three patients with acute leukemia and review of the literatureFuhong Liu, Song Xue, Yongping Zhang, et al.
Clinical and Experimental Pharmacology & Physiology|June 2, 2022
Dihydroartemisinin protects blood-brain barrier permeability during sepsis by inhibiting the transcription factor SNAI1Fuhong Liu, Jing Liu, Hongjie Xiang, et al.
Leukemia & Lymphoma|April 20, 2022
Rapid response to avapritinib of acute myeloid leukemia with t(8;21) and <i>KIT</i> mutation relapse post allo-HSCTSong Xue, Wenqiu Huang, Fuhong Liu, et al.
International Journal of Laboratory Hematology|April 11, 2024
FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantationSong Xue, Wenqiu Huang, Yongping Zhang, et al.
Autoimmunity|February 25, 2015
STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopeniaZhenping Chen, Zhenxing Guo, Jingyao Ma, et al.
Cancer Chemotherapy and Pharmacology|December 23, 2023
Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathwayLiru Huang, Fuhong Liu, Xukai Liu, et al.
Annals of Hematology|November 10, 2022
Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioningWenqiu Huang, Song Xue, Yongping Zhang, et al.
Fundamental & Clinical Pharmacology|October 27, 2020
Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cellsFengyun Dong, Xinghai Zhao, Jianning Wang, et al.
Pageof 4